Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-25

FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves lisdexamfetamine dimesylate (generic) from Mylan as an Original Application; the generic is approved for the same indications as the brand: attenti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LISDEXAMFETAMINE DIMESYLATE (Lisdexamfetamine dimesylate)

Snippet

ORIG AP for LISDEXAMFETAMINE DIMESYLATE (LISDEXAMFETAMINE)